V Partners

Israeli VC firm investing in early-stage startups and partnering with innovative entrepreneurs to build category-defining companies.

Venture Capital Active Tel Aviv, Israel Est. 2015
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
total disclosed, rounds participated
Stages

About

TLV Partners is an Israeli venture capital firm founded in 2015 that manages over $1 billion in assets across five funds. They specialize in seed and Series A investments, supporting Israeli technology founders across sectors such as cybersecurity, data infrastructure, artificial intelligence, developer tools, fintech, biotechnology, and e-commerce. The firm aims to provide strategic guidance and network access in addition to capital, with a focus on building long-term partnerships with its portfolio companies.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

1 portfolio exit on record.

Portfolio by sector

Cyber Security1
Health Tech & Life Sciences1

Q&A

What is V Partners' most recent notable exit?
V Partners had a notable exit in September 2020 when PainReform went public on NASDAQ with a valuation of $70M, having raised $23M in capital.
What sectors does V Partners focus on for investments?
V Partners has shown a focus on Cyber Security and Health Tech & Life Sciences, with one portfolio company in each sector.
Can you name some of V Partners' portfolio companies?
V Partners' portfolio includes CYE, a cyber-security optimization solutions provider, and PainReform, which develops pain treatment drugs.
When did V Partners make its most recent investment?
V Partners made an investment in June 2018, according to startupim data.
What is the business model of V Partners' portfolio company CYE?
CYE, a portfolio company of V Partners, operates with a B2B business model, providing cyber-security optimization solutions.
What is the business model of V Partners' portfolio company PainReform?
PainReform, a portfolio company of V Partners, operates with both B2B and B2B2C business models, focusing on pain treatment drugs.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2015-1

Radar intelligence

Patents

EPO192